Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort

被引：10

作者：

Casco, Nicolas ^{[1
]}

Levi Jorge, Alberto ^{[1
]}

Juan Palmero, Domingo ^{[1
]}

Alffenaar, Jan-Willem ^{[2
,3
,4
]}

Fox, Greg J. ^{[5
]}

Ezz, Wafaa ^{[5
]}

Cho, Jin-Gun ^{[2
,6
,7
]}

Denholm, Justin ^{[8
,9
]}

Skrahina, Alena ^{[10
]}

Solodovnikova, Varvara ^{[10
]}

Arbex, Marcos Abdo ^{[11
]}

Alves, Tatiana ^{[12
]}

Rabahi, Marcelo Fouad ^{[13
]}

Pereira, Giovana Rodrigues ^{[14
]}

Sales, Roberta ^{[15
]}

Silva, Denise Rossato ^{[16
]}

Saffie, Muntasir M. ^{[17
]}

Escobar Salinas, Nadia ^{[18
]}

Caamano Miranda, Ruth ^{[19
]}

Cisterna, Catalina ^{[19
]}

Concha, Clorinda ^{[19
]}

Fernandez, Israel ^{[19
]}

Villalon, Claudia ^{[19
]}

Guajardo Vera, Carolina ^{[19
]}

Gallegos Tapia, Patricia ^{[19
]}

Cancino, Viviana ^{[20
]}

Carbonell, Monica ^{[20
]}

Cruz, Arturo ^{[20
]}

Munoz, Eduardo ^{[20
]}

Munoz, Camila ^{[20
]}

Navarro, Indira ^{[20
]}

Pizarro, Rolando ^{[20
]}

Cristina Sanchez, Gloria Pereira ^{[20
]}

Vergara Riquelme, Maria Soledad ^{[20
]}

Vilca, Evelyn ^{[20
]}

Soto, Aline ^{[20
]}

Flores, Ximena ^{[21
]}

Garavagno, Ana ^{[21
]}

Hartwig Bahamondes, Martina ^{[21
]}

Moyano Merino, Luis ^{[21
]}

Maria Pradenas, Ana ^{[21
]}

Espinoza Revillot, Macarena ^{[21
]}

Rodriguez, Patricia ^{[21
]}

Serrano Salinas, Angeles ^{[22
]}

Taiba, Carolina ^{[22
]}

Farias Valdes, Joaquin ^{[23
]}

Navarro Subiabre, Jorge ^{[24
]}

Ortega, Carlos ^{[25
]}

Palma, Sofia ^{[26
]}

Perez Castillo, Patricia ^{[27
]}

机构：

[1] Inst Tisioneumonol Prof Dr R Vaccarezza, Buenos Aires, Argentina

[2] Univ Sydney, Sydney Inst Infect Dis, Sydney, Australia

[3] Univ Sydney, Sch Pharm, Fac Med & Hlth, Sydney, Australia

[4] Westmead Hosp, Sydney, Australia

[5] Univ Sydney, Sydney Sch Med, Fac Med & Hlth, Sydney, Australia

[6] Parramatta Chest Clin, Parramatta, Australia

[7] Westmead Hosp, Westmead, Australia

[8] Melbourne Hlth, Victorian TB Program, Melbourne, Vic, Australia

[9] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Infect Dis, Parkville, Australia

[10] Republican Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS

[11] Univ Araraquara, Fac Med, Area Temat Pneumol, Araraquara, Brazil

[12] Univ Fed Bahia, Salvador, Brazil

[13] Univ Fed Goias, Fac Med, Goiania, Go, Brazil

[14] Secretaria Municipal Saude, Lab Municipal Alvorada, Alvorada, Brazil

[15] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Inst Coracao,Div Pneumol, Sao Paulo, Brazil

[16] Univ Fed Rio Grande do Sul UFRGS, Fac Med, Porto Alegre, Brazil

[17] McMaster Univ, Div Respirol, Hamilton, ON, Canada

[18] Minist Salud Chile, Programa Nacl TB, Santiago, Chile

[19] Serv Salud Metropolitano Cent, Santiago, Chile

[20] Serv Salud Metropolitano Sur, Santiago, Chile

[21] Serv Salud Metropolitano Oriente, Providencia, Chile

[22] Serv Salud Metropolitano Occidente, Santiago, Chile

[23] Serv Salud Iquique, Iquique, Chile

[24] Serv Salud Valparaiso San Antonio, Valparaiso, Chile

[25] Serv Salud Concepcion, Concepcion, Chile

[26] Hosp DIPRECA, Las Condes, Chile

[27] Serv Salud Antofagasta, Antofagasta, Chile

[28] Serv Salud Magallanes, Punta Arenas, Chile

[29] Serv Salud Talcahuano, Talcahuano, Chile

[30] Serv Salud Arica, Arica, Chile

[31] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China

[32] Minist Salud & Protecc Social, Bogota, Colombia

[33] Secretaria Salud Dept, Cauca, Colombia

[34] Univ Cauca, Dept Med Interna, Grp Invest TB, Popayan, Colombia

[35] Catholic Univ Cuenca, Cuenca, Ecuador

[36] WHO Reg Off Eastern Mediterranean Reg, Cairo, Egypt

[37] CHU Amiens Picardie, Resp Dept, Amiens, France

[38] Picardie Jules Verne Univ, UR 4294, AGIR, Amiens, France

[39] Nantes Univ, CHU Nantes, Inst Thorax, Serv Pneumol, Nantes, France

[40] Grp Hosp Sud Ile de France GHSIF, Serv Pneumol, Melun, France

[41] Intermunicipal Hosp Ctr Creteil, Dept Internal Med, Creteil, France

[42] North Cardiol Ctr, Pneumol Dept, St Denis, France

[43] Hop Instruct Armees Percy, Dept Pneumol, Clamart, France

[44] Hop Univ Henri Mondor, AP HP, Unite Pneumol, Creteil, France

[45] Univ Paris Est Creteil, Fac Sante, INSERM, IMRB, Creteil, France

[46] Aristotle Univ Thessaloniki, Pulm Dept, Thessaloniki, Greece

[47] Univ Gamal Abdel Nasser Conakry, CHU Conakry, Fac Sci & Tech Sante, Serv Pneumophtisiol, Conakry, Guinea

[48] Hop Natl Ignace Deen, Conakry, Guinea

[49] Damien Fdn, Conakry, Guinea

[50] Secretaria Salud Honduras, Natl TB Programme, Tegucigalpa, Honduras

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷 / 05期

关键词：

EXTREMELY PRETERM; LUNG-FUNCTION; SCHOOL-AGE; BIRTH; EXERCISE; CHILDREN; INFANTS; IMPAIRMENT; SURVIVORS; MEMBRANE;

D O I：

10.1183/13993003.00925-2023

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Background Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes of patients affected by TB and COVID-19. Methods We collected data from 174 centres in 31 countries on all patients affected by COVID-19 and TB between 1 March 2020 and 30 September 2022. Patients were followed-up until cure, death or end of cohort time. All patients had TB and COVID-19; for analysis purposes, deaths were attributed to TB, COVID-19 or both. Survival analysis was performed using Cox proportional risk-regression models, and the log-rank test was used to compare survival and mortality attributed to TB, COVID-19 or both. Results Overall, 788 patients with COVID-19 and TB (active or sequelae) were recruited from 31 countries, and 10.8% (n=85) died during the observation period. Survival was significantly lower among patients whose death was attributed to TB and COVID-19 versus those dying because of either TB or COVID-19 alone (p<0.001). Significant adjusted risk factors for TB mortality were higher age (hazard ratio (HR) 1.05, 95% CI 1.03-1.07), HIV infection (HR 2.29, 95% CI 1.02-5.16) and invasive ventilation (HR 4.28, 95% CI 2.34-7.83). For COVID-19 mortality, the adjusted risks were higher age (HR 1.03, 95% CI 1.02-1.04), male sex (HR 2.21, 95% CI 1.24-3.91), oxygen requirement (HR 7.93, 95% CI 3.44- 18.26) and invasive ventilation (HR 2.19, 95% CI 1.36-3.53). Conclusions In our global cohort, death was the outcome in >10% of patients with TB and COVID-19. A range of demographic and clinical predictors are associated with adverse outcomes.

引用

页数：12

共 50 条

[41] Co-Infection Tuberculosis/Covid 19. An Announced Tragedy?
Arbex, M. A.
Porto, C. L. P.
Pirolla, G. A. K.
Dognani, M., I
Elia, I. D.
Abreu, B. C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[42] Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review
Tsheten Tsheten
Archie C. A. Clements
Darren J. Gray
Ripon K. Adhikary
Kinley Wangdi
BMC Infectious Diseases, 21
[43] Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review
Tsheten, Tsheten
Clements, Archie C. A.
Gray, Darren J.
Adhikary, Ripon K.
Wangdi, Kinley
BMC INFECTIOUS DISEASES, 2021, 21 (01)
[44] Mortality and Clinical Outcomes of Aspergillus and COVID-19 Co-infection: A Retrospective Analysis
Cazzaniga, Juliana
Koutras, Nicole
Patel, Premalkumar
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
[45] Long-term outcomes of COVID-19 infection in patients with solid tumors before vaccination
Yazici, O.
Unsal, O.
Ozkan, O. F.
Ozdemir, N.
Tahtaci, G.
Uner, A.
Gunel, N.
Ozet, A.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S776 - S776
[46] Co-infection of COVID-19 and pulmonary tuberculosis: a case report on lung and liver damage
Bereda, Gudisa
ANNALS OF MEDICINE AND SURGERY, 2025, 87 (04): : 2346 - 2348
[47] Dynamical analysis of COVID-19 and tuberculosis co-infection using mathematical modelling approach
Akanni, J. O.
Ajao, S.
Abimbade, S. F.
Fatmawati
MATHEMATICAL MODELLING AND CONTROL, 2024, 4 (02): : 208 - 229
[48] Survival from a Triple Co-Infection of COVID-19, HIV, and Tuberculosis: A Case Report
Tolossa, Tadesse
Tsegaye, Reta
Shiferaw, Siraj
Wakuma, Bizuneh
Ayala, Diriba
Bekele, Belay
Shibiru, Tesfaye
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 611 - 615
[49] Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital
Stochino, Claudia
Villa, Simone
Zucchi, Patrizia
Parravicini, Pierpaolo
Gori, Andrea
Raviglione, Mario Carlo
EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (01)
[50] Incidence and co-infection with COVID-19 of dengue during the COVID-19 pandemic
Hung, Yuan-Pin
Lee, Ching-Chi
Chen, Ying-Wen
Lee, Jen-Chieh
Chiu, Chun-Wei
Hsueh, Po-Ren
Ko, Wen-Chien
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2025, 124 (03) : 206 - 211

← 1 2 3 4 5 →